Life

Why “secondary” excess mortality and mortality assumption uncertainty is in fact likely to continue for several more years.
 

The new American Psychiatric Association’s (APA) “Diagnostic and Statistical Manual (DSM) of Mental Disorders”, Fifth Edition, Text Revision (DSM‑5‑TR) was released in March. It’s been nine years since the publication DSM 5, so an update was overdue.
 

Immunotherapy works by enhancing the immune system rather than directly attacking cancer cells. RGA’s clinical oncologist, Dr. Radi Counsell, discusses how modern approaches to immunotherapy are transforming cancer survival rates for individuals fighting aggressive cancers. In addition, Dr. Counsell will examine the underwriting and claims adjudication implications.

This second article in SCOR’s Extreme Sports series will focus on risks associated with athletic cycling, both amateur and professional, in order to provide underwriters with a deeper understanding of how cycling risks should be considered during the insurance application process.

In this edition of ReCent Medical News, Monique Esterhuizen reflects on how genomics enable us to “look under the hood” of a tumor and develop the most suitable personalized treatment. Furthermore she explores what insurers need to know about these promising cancer treatments.
 

Understanding the outbreak and its impact for insurers
 

Neurotechnology is defined as “the application of engineering principles to the understanding, engagement, and repair of the human nervous system.” In this research article, RGA's Hilary Henly, Global Medical Researcher, highlights how the enhanced understanding of how the brain functions and how technology can interact with brain waves is creating new approaches to treat severe or advanced neurological disorders, allowing patients to live longer and healthier lives.

Recent allegations of racial bias and discrimination in marketing, rating, underwriting, and claims practices by insurance companies and other licensees have come to light nationwide.